Journals / Turkish Journal of Gastroenterology / 2014 / Cilt: 25 - Sayı: 2

Value of expression of insulin-like growth factor-1 receptor in gastric adenocarcinomas and normal gastric tissues STOMACH

Pages
141–146
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Metastatic progression reduces IGF-1R expression gradually in cancer tissue.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/Aims: Insulin-like growth factor-1 receptor (IGF-1R) plays critical roles in cell proliferation, differentiation, apoptosis, and transformation.
📊
Key Findings & Data:Suppression of IGF-1R by means of antisense methods and specific antibodies causes cell apoptosis and growth inhibition of cancer cells.
💡
Conclusion & Impact:Metastatic progression reduces IGF-1R expression gradually in cancer tissue.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Background/Aims: Insulin-like growth factor-1 receptor (IGF-1R) plays critical roles in cell proliferation, differentiation, apoptosis, and transformation. Suppression of IGF-1R by means of antisense methods and specific antibodies causes cell apoptosis and growth inhibition of cancer cells. The present study aims to investigate whether there is a difference between normal and cancerous tissue with respect to IGF-1R expression and to assess the relationship between IGF-1R expression and tumor stage, degree of differentiation, and lymph node metastasis by examining IGF-1R expression in cancerous and normal tissues of gastric adenocarcinoma cases of different stages.Materials and Methods: By using immunohistochemical methods, IGF-1Rb (H-60) (1/100, Santa Cruz Biotechnology, SC-9038, Texas,USA) expression was investigated in paraffin-embedded blocks obtained from total/partial gastrectomy material pertaining to 47 gastric adenocarcinoma cases. IGF-1R expression was evaluated semi-quantitatively in terms of intensity and distribution in both normal and cancerous tissues.Results: Insulin-like growth factor-1 receptor expression mean score was 5.38 and 8.40 for cancerous and for normal gastric tissues, respectively. IGF-1R expression decreased significantly in cancerous tissues compared normal tissue (p:0.001). When all cases with and without lymph node metastasis were analyzed, IGF-1R expression was observed to decrease for cases with lymph node metastasis compared to those without lymph node metastasis (p:0.035).Conclusion: Insulin-like growth factor-1 receptor expression in gastric cancer tissue has proven to be considerably lower than IGF-1R expression in normal gastric mucosa. Metastatic progression reduces IGF-1R expression gradually in cancer tissue.

🔖

Cite This Article

TOPALAK, Ö., KANTAR, F. U., ULUKUŞ, Ç., KÜPELİOĞLU, A. (2014). Value of expression of insulin-like growth factor-1 receptor in gastric adenocarcinomas and normal gastric tissues STOMACH. Turkish Journal of Gastroenterology, Cilt: 25 - Sayı: 2, 141–146. https://ajindex.com/articles/410273

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108. [CrossRef] Vincent AM, Feldman EL. Control of cell survival by IGF signaling pathways. Growth Horm IGF Res 2002; 12: 193-7. [CrossRef] Moschos SJ, Mantzoros CS. The role of the IGF system in cancer: From basic to clinical studies and clinical applications. Oncology 2002; 63: 317-32. [CrossRef] Grothey A, Voigt W, Schöber C, Müller T, Dempke W, Schmoll HJ. The role of insulin-like growth factor I and its receptor in cell growth, transformation, apoptosis and chemoresistance in solid tumors. J Cancer Res Clin Oncol 1999; 125: 166-73. [CrossRef] Wener H, Roberts CT Jr. The IGFI receptor gene: a molecular target for disrupted transcription factors. Genes Chromosomes Cancer 2003; 36: 113-20. [CrossRef] Valentinis B, Porcu PL, Quinn K, Basserga R. The role of the insulin- like growth factor I receptor in the transformation by simian virus 40 T antigen. Oncogene 1994; 9: 825-31.
  2. Sell C, Rubini M, Rubin R, Liu JP, Efstratiadis A, Baserga R. Simian vi- rus 40 large tumor antigen is unable to transform mouse embry- onic fibroblasts lacking type 1 insulin-like growth factor receptor. Proc Natl Acad Sci USA 1993; 90: 11217-21. [CrossRef] Coppola D, Ferber A, Miura M et al. A functional insulin-like growth factor I receptor is required for the mitogenic and trans- forming activities of the epidermal growth factor receptor. Mol Cell Biol 1994; 14: 4588-95.
  3. Jiang Y, Rom WN, Yie TA, Chi CX, Tchou-Wong KM. Induction of tumor suppression and glandular differentiation of A549 lung carcinoma cells by dominant-negative IGF-I receptor. Oncogene 1999; 18: 6071-7. [CrossRef] Adachi Y, Lee CT, Coffee K et al. Effects of genetic blockade of the insulin-like growth factor receptor in human colon cancer cell lines. Gastroenterology 2002; 123: 1191-204. [CrossRef] Reinmuth N, Fan F, Liu W et al. Impact of insulin-like growth factor receptor I function on angiogenesis, growth and metastasis of colon cancer. Lab Invest 2002; 82: 1377-99. [CrossRef] Sachdev D, Li SL, Hartell JS, Fujita-Yamaguchi Y, Miller JS, Yee D. A chimeric humanized single-chain antibody against the type-1 IGF receptor renders breast cancer refractory to the mitogenic effect of IGF-I. 2003. Cancer Res 2003; 63: 627-35.
  4. Resnicoff M, Coppola D, Sell C, Rubin R, Ferrone S, Baserga R. Growth inhibition of human melanoma cells in nude mice by an- tisense strategies to the type 1 IGF receptor. Cancer Res 1994; 54: 4848